Nicole Wempen, | |
7200 Forestview Ln N, Maple Grove, MN 55369-5571 | |
(763) 200-1466 | |
Not Available |
Full Name | Nicole Wempen |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 7200 Forestview Ln N, Maple Grove, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215588736 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 304144 (Minnesota) | Secondary |
1041C0700X | Social Worker - Clinical | 23220 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nicole Wempen, 12600 Porcupine Ct, Eden Prairie, MN 55344-3923 Ph: (952) 594-5061 | Nicole Wempen, 7200 Forestview Ln N, Maple Grove, MN 55369-5571 Ph: (763) 200-1466 |
News Archive
We operate nationwide, giving advice and support to all of our members to allow them to develop and grow their businesses. We do this by giving bespoke support in areas such as innovation - from concept to commercialisation, public relations, international trade – including access to many export markets, market research and guidance on procurement as well as many other areas.
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells.
On Sunday, November 15, 2009, Florida Atlantic University (FAU) researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Association's Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of aspirin used in clinical practice increase nitric oxide.
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force -; at a cost of $478 million per year.
Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share.
› Verified 6 days ago